Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Aug 30, 2023

In this episode, we delve into a new horizon in the management of acute agitation. We discuss dexmedetomidine, a drug that's been around since 1999, recently reformulated into a sublingual film and FDA approved for treating agitation associated with schizophrenia or bipolar I or II disorder. We explore the results from a recent randomized trial and its potential for transforming psychiatric care.

Faculty: Jim Phelps, M.D.
Host: Richard Seeber, M.D.